FDA Inspection 1342926 — Anna Olech-Cudzik, MD
The FDA completed an inspection of Anna Olech-Cudzik, MD on Oct 23, 2026 in Ostrowiec Swietokrzyski. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 23, 2026
- Fiscal Year
- 2027
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Ostrowiec Swietokrzyski (Poland)
Additional Details
Clinical Investigator (CI)